Trygg Pharma AS – a company that will be jointly owned by Aker BioMarine ASA and an affiliate of Lindsay Goldberg LLC through a newly established joint venture company (cf. the separate notice of today) – has entered into an agreement to acquire 100% of the shares in Epax Holding AS (together with its subsidiaries “Epax”), a wholly owned subsidiary of Austevoll Seafood ASA. Epax is the world’s premier high concentrate omega-3 supplement manufacturer. Epax employs a total of 74 people.
In July 2013, FMC Corporation acquired Epax Nutra Holding III AS (Norway) and Epax UK Holding III AS (United Kingdom) (together, Epax)
EU Moves to Shield Tuna Cannery Industry from Thai Competition European Union
European Commission Proposes Tariff Exemptions Conditional on Raw Material Caught Exclusively by Union Fleet
The European Union faces a decisive moment for the future of its fishing and processing se...
Oceanus peruvianus: when the Pacific was Peruvian Peru
A historical journey through the maritime prominence of Peru, from ancient indigenous navigation and the colonial viceroyalty era to the 200-mile declaration and the modern challenge of rebuilding a l...
Trygg Pharma AS
Personal Profile
Shareholder companies:
Print
